Skip to Main Content

Paper Details

Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
Clin Breast Cancer
23
2007
Author NameAffiliation
Eleni AndreopoulouNew York University Medical Center
  • 1 - 1

Datasets

Release 1.2